Putnam Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
SCM
CS
BCM
Putnam Investments's IRWD Position: Q4 2022 in Review
Putnam Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2022, closing a stake of 1,510,792 shares — an estimated $15.7M sold.
Putnam Investments first reported a position in IRWD in Q2 2018 and held it in 14 quarters. The position peaked at $71.6M in Q3 2021. 249 funds tracked by Wall St. Rank hold IRWD as of Q4 2022.
- Putnam Investments reported no remaining Ironwood Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Putnam Investments sold 1,510,792 Ironwood Pharmaceuticals shares in Q4 2022, an estimated $15.7M.
- Putnam Investments first reported a position in Ironwood Pharmaceuticals in Q2 2018 and held it in 14 quarters.
- Putnam Investments's Ironwood Pharmaceuticals position peaked at $71.6M in Q3 2021.
- 249 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2022.
Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.